CAR-T Meeting 2021 | CAR-T therapy: treatment burden and costs
Erik Aerts
• 4 Feb 2021
Erik Aerts, RN, Hematology Nurses and Healthcare Professionals Group, Winterthur, Switzerland, details the topics discussed during the group discussion on the ethics of CAR T-cell therapy. The group debated how patients are affected by the burden of treatment and the costs of CAR T-cell therapy. This interview took place during the 3rd European CAR T-cell Meeting.
